Burning Rock Biotech (BNR) Assets Average (2020 - 2025)

Burning Rock Biotech's Assets Average history runs 6 years deep, the most recent figure standing at $114.9 million for Q4 2025.

• In Q4 2025, Assets Average fell 12.83% year-over-year to $114.9 million; the TTM figure through Dec 2025 stood at $114.9 million (down 12.83% YoY), while the FY2025 annual figure was $119.3 million, down 10.89% from the prior year.
• Assets Average was $114.9 million for Q4 2025 at Burning Rock Biotech, roughly flat from $114.6 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $405.6 million in Q1 2021 to a low of $114.6 million in Q3 2025.
• Historically, Assets Average has averaged $222.7 million across 5 years, with a median of $183.3 million in 2023.
• The sharpest annual moves came in 2021 and 2023: Assets Average decreased 7.15% in 2021, then plunged 37.64% in 2023.
• A 5-year view of Assets Average shows it stood at $366.5 million in 2021, then slumped by 36.34% to $233.3 million in 2022, then sank by 34.77% to $152.2 million in 2023, then decreased by 13.4% to $131.8 million in 2024, then declined by 12.83% to $114.9 million in 2025.
• The last three Assets Average figures came in at $114.9 million (Q4 2025), $114.6 million (Q3 2025), and $116.5 million (Q2 2025), per Business Quant data.